Sunwin Stevia International, Inc. (SUWN)
$0.0053
0.00 (0.00%)
Rating:
Recommendation:
-
| Symbol | SUWN |
|---|---|
| Price | $0.0053 |
| Beta | 0.933 |
| Volume Avg. | 0.05M |
| Market Cap | 1.058M |
| Shares () | - |
| 52 Week Range | 0.0053-0.03 |
| 1y Target Est | - |
| DCF Unlevered | SUWN DCF -> | |
|---|---|---|
| DCF Levered | SUWN LDCF -> | |
| ROE | -24.06% | Sell |
| ROA | -6.58% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 354.37% | Strong Buy |
| P/E | - | |
| P/B | 0.17 | Neutral |
About
Download (Excel)Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It offers Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.